Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-02
DOI
10.1002/ptr.6355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells
- (2018) Lei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer
- (2018) Weishan Zhuge et al. CANCER LETTERS
- Costunolide promotes imatinib-induced apoptosis in chronic myeloid leukemia cells via the Bcr/Abl-Stat5 pathway
- (2018) Hong Cai et al. PHYTOTHERAPY RESEARCH
- Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
- (2018) Min Hu et al. GENE
- Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors
- (2017) Ami B. Patel et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
- (2017) H Zhou et al. LEUKEMIA
- Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
- (2017) Meenu Kesarwani et al. NATURE MEDICINE
- Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway
- (2017) Zhangxiao Peng et al. Scientific Reports
- Treatment of chronic myelogenous leukemia
- (2016) C. Kujak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The apoptotic members CD95, BclxL and Bcl-2 cooperate to promote cell migration by inducing Ca2+ flux from the endoplasmic reticulum to mitochondria
- (2016) A Fouqué et al. CELL DEATH AND DIFFERENTIATION
- BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts
- (2015) Q Li et al. CANCER GENE THERAPY
- Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice
- (2015) Carolina Vicente-Dueñas et al. Oncotarget
- Growth Inhibition Effects of Isoalantolactone on K562/A02 Cells: Caspase-dependent Apoptotic Pathways, S Phase Arrest, and Downregulation of Bcr/Abl
- (2014) Hong Cai et al. PHYTOTHERAPY RESEARCH
- The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
- (2013) Sylwester Glowacki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now